MedPath

Effect of Jujube Oxymel in Chronic Urticaria

Phase 2
Recruiting
Conditions
Chronic Urticaria.
Other urticaria: chronic spontaneous urticaria
L50.8
Registration Number
IRCT20200201046328N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
106
Inclusion Criteria

Patients with chronic urticaria with doctor confirmation
12 to 65 years old
Male and female
Have tendency for entering into study
Not using any anti urticaria medications during the past week

Exclusion Criteria

Pregnancy & breast-feeding
Having severe angioedema
Having uncontrolled cardiovascular, respiratory, hematologic, urology, immune system, infectious and diabetes
Having sensitivity to antihistamine drugs
Having sensitivity to Jujube plant

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quantity of hives. Timepoint: First of research, 7,14,21,28,56 days after intervention. Method of measurement: Urticaria Activity Score (UAS) questionnaire.;Level of itch. Timepoint: First of research, 7,14,21,28,56 days after intervention. Method of measurement: Urticaria Activity Score (UAS) questionnaire.;Quality of life. Timepoint: First of research, fourth and eighth weeks of study. Method of measurement: Quality of Life Questionnaire of chronic urticaria CU-Q2oL.
Secondary Outcome Measures
NameTimeMethod
Sides effects. Timepoint: Fourth and eighth weeks of the study. Method of measurement: Common Terminology Criteria for Adverse Events v5.0 2017.
© Copyright 2025. All Rights Reserved by MedPath